Liangliang Dai | Drug Delivery Systems | Best Researcher Award

Posted on by sciencefather

Liangliang Dai | Drug Delivery Systems | Best Researcher Award

Prof  Liangliang Dai, Northwestern Polytechnical University, China

Prof. Liangliang Dai Associate Professor & Assistant Dean, Institute of Medical Research, Northwestern Polytechnical University. With a PhD and MD in Biomedical Engineering and Biology from Chongqing University under Prof. Kaiyong Cai, Prof. Dai’s research focuses on nanomaterials, drug delivery systems, nanosystems, tumor immunotherapy, and antimetabolic therapy. He has led multiple national and provincial research projects and published in top journals like Nature Communications and Advanced Functional Materials. His innovative work bridges nanotechnology and cancer therapy, advancing biomedical science. 🔬🌿

Publication Profile

orcid

Education Background

Prof. Liangliang Dai holds a Ph.D. in Biomedical Engineering 🎓 from the Ministry of Education College of Bioengineering at Chongqing University, where he conducted advanced research under the mentorship of Prof. Kaiyong Cai. His academic journey also includes an MD in Biology 🧬 from the same institution, further solidifying his expertise in bioengineering and biomedical sciences. Guided by Prof. Cai, his studies focused on cutting-edge innovations in the field. With a strong foundation in interdisciplinary research, Prof. Dai continues to contribute to scientific advancements in biomedical engineering and biology, shaping the future of healthcare and biotechnology 🔬.

Hosted Research Project

Prof. Liangliang Dai has led several prestigious research projects 🔬, contributing significantly to biomedical engineering. He has been awarded funding from the National Natural Science Foundation of China 🏅 for multiple projects (52373157, 52003223) and has received the National Science Foundation for Distinguished Young Scholars of Shaanxi Province (S2025-JC-JQ-0228). Additionally, he has played a key role in the Key R&D Programs of Shaanxi Province (2024SF2-GJHX-26, 2022SF-012) and secured support from the Natural Science Foundation of Shaanxi Province (2019JQ-347) and the Young Talent Fund of University Association for Science and Technology (20200302) 🌍.

Research Contributions

Prof. Liangliang Dai has secured multiple prestigious research grants 🏅, including funding from the National Natural Science Foundation of China and the Key R&D Program of Shaanxi Province. His research focuses on advanced drug delivery systems 💊, tumor immunotherapy 🧬, and biomedical nanotechnology 🔬, making significant contributions to the medical research community. These competitive grants reflect his expertise and the high regard for his work in the scientific field. Through pioneering innovations, Prof. Dai continues to push the boundaries of biomedical engineering, striving for breakthroughs that enhance healthcare and therapeutic solutions globally 🌍.

Global Recognition 

Prof. Liangliang Dai is a globally recognized researcher 🌍, collaborating with renowned scientists to develop innovative therapeutic strategies 🔬. His groundbreaking work in cancer therapy 🧬 and nanomaterial-based drug delivery 💊 is paving the way for more effective medical treatments. Beyond securing prestigious grants and publishing impactful research, his contributions hold practical significance in biomedical applications, transforming healthcare solutions. With a commitment to advancing science, Prof. Dai’s influence continues to grow, driving innovation and shaping the future of medicine through cutting-edge technologies and interdisciplinary collaborations 🤝.

Innovative Research

Prof. Liangliang Dai’s research is highly interdisciplinary 🔬, blending nanotechnology, immunotherapy, and bioengineering to advance medical science. His groundbreaking work on multifunctional metal-organic frameworks 🏗️, light-activatable antibiosis for infected bone repair 🦴, and tumor microenvironment modulation 🧬 showcases his pioneering role in translational medicine. By enhancing cancer treatment strategies 🎗️ and optimizing drug delivery systems 💊, his studies have a direct impact on healthcare. Through cutting-edge innovations, Prof. Dai is shaping the future of biomedical science, driving transformative solutions that improve patient outcomes and therapeutic effectiveness worldwide 🌍.

Research Focus

Liangliang Dai’s research primarily focuses on nanotechnology and biomedical engineering 🧪🔬, with a particular emphasis on nanosystems for drug delivery, tumor therapy, and environmental applications. His work explores nanoparticles, metal-organic frameworks (MOFs), and photo-responsive materials to develop advanced cancer treatments 🎗️, chemodynamic therapy ⚛️, immune modulation 🛡️, and antimicrobial strategies 🦠. Dai also investigates water purification 💧 and biofilm control to tackle antibiotic resistance. His research bridges materials science 🏗️ and biomedicine to create multifunctional therapeutic nanosystems, advancing precision medicine 🧬 and environmental health 🌍.

Publication Top Notes

Nanosilver-Induced Pseudo Cuproptosis of Potentially Pathogenic Bacteria during the Storage of Ozone-Treated Wastewater

MMP-2/GSH-responsive nanobomb for tumor chemo-immunotherapy with hierarchical delivery and TAMs re-education by regulating hbegf-activated ERK/MAPK signal pathway

An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells.

Multifunctional Fe-based coordination polymer nano-bomb modified with β-lapachone and CaO<sub>2</sub> for targeted tumor dual chemodynamic therapy with enhanced ferroptosis and H<sub>2</sub>O<sub>2</sub> self-supply.

A Photo‐Therapeutic Nanocomposite with Bio‐Responsive Oxygen Self‐Supplying Combats Biofilm Infections and Inflammation from Drug‐Resistant Bacteria

Detachable MOF-Based Core/Shell Nanoreactor for Cancer Dual-Starvation Therapy With Reversing Glucose and Glutamine Metabolisms.

Engineered drug delivery nanosystems for tumor microenvironment normalization therapy

Cascade amplification of tumor chemodynamic therapy and starvation with re-educated TAMs via Fe-MOF based functional nanosystem

Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Xuzhou Medical University, China

Author Profile

🎓Early Academic Pursuits 

Liqun Jiang began his academic journey with a deep interest in pharmaceutical sciences and biotechnology. His foundational studies were driven by a passion for discovering innovative solutions to pressing medical challenges. During his early years, Jiang demonstrated exceptional aptitude in the fields of drug development and delivery systems, excelling in both theoretical and applied sciences. These formative experiences laid the groundwork for his future endeavors in advanced pharmaceutical research. Jiang’s dedication to academic excellence led him to pursue specialized training and advanced education, equipping him with the knowledge and skills essential for groundbreaking contributions to medical science.

🌟Professional Endeavors 

Currently serving as an Associate Professor at Xuzhou Medical University, Liqun Jiang has established himself as a key figure in pharmaceutical engineering. His role extends beyond teaching, as he actively participates in high-impact research initiatives. A youth member of the Pharmaceutical Engineering Committee of the Chinese Pharmaceutical Society, Jiang is deeply involved in projects focused on novel drug delivery systems, particularly for respiratory diseases.

He has been instrumental in nearly 10 prestigious research projects, including the national 863 Program and major drug innovation programs. Jiang has successfully overseen the development of approximately 10 products, ranging from pharmaceuticals and disinfection solutions to specialized medical foods. His collaborative efforts with pharmaceutical companies have led to the development of a drug liposome inhalation agent, which has now progressed to pilot production stages.

🔬Contributions and Research Focus 

Jiang Liqun’s research is primarily centered on novel drug delivery systems for respiratory diseases, with a particular emphasis on pulmonary edema. His contributions to the field are both diverse and impactful, including: Developing pressure-sensitive multivesicular liposomes for delivering amlodipine besylate, Innovating therapies with exogenous eNOS genes to combat high-altitude pulmonary edema, Utilizing mesenchymal stem cell exosomes for advanced inhalation therapies, Designing high-efficiency powder mist inhalants for high-altitude conditions.

🏆Accolades and Recognition 

Liqun Jiang’s academic and professional achievements have garnered widespread recognition. His research contributions are evidenced by: Nearly 30 peer-reviewed publications in reputed journals, 10 authorized patents, with 8 more under processing, An impressive citation index of 312, reflecting the high impact of his work, Close collaborations with pharmaceutical companies, leading to tangible advancements in drug development and commercialization, Jiang’s dedication to his field is further highlighted by his active participation in the Chinese Pharmaceutical Society, where he contributes as a youth member in shaping the future of pharmaceutical engineering.

🌏Impact and Influence 

Jiang Liqun’s work has had a profound impact on both academia and industry. His innovative strategies for addressing respiratory diseases have paved the way for safer, more effective therapeutic interventions. By integrating cutting-edge drug delivery systems into clinical practice, Jiang has set a benchmark in the treatment of pulmonary conditions. His ability to bridge the gap between research and application has made him a valuable collaborator for pharmaceutical companies seeking to bring advanced therapies to market.

🌟Legacy and Future Contributions 

Jiang Liqun’s legacy lies in his relentless pursuit of innovation and excellence in pharmaceutical research. His groundbreaking work in drug delivery systems has already influenced the development of treatments for high-altitude pulmonary edema and other respiratory conditions. Looking ahead, Jiang aims to expand his research into broader areas of pulmonary medicine, focusing on the use of biotechnology and nanotechnology in drug development. He envisions a future where precision medicine and targeted therapies play a pivotal role in treating respiratory diseases, improving outcomes for patients worldwide. Jiang is committed to mentoring the next generation of researchers and fostering collaborations that advance the frontiers of pharmaceutical science.

🌟Final Thoughts 

With a career marked by innovation, dedication, and impactful contributions, Liqun Jiang exemplifies the qualities of a trailblazing researcher. His work continues to shape the future of respiratory medicine, leaving an indelible mark on both academia and industry. Through his ongoing efforts, Jiang inspires a new wave of scientific inquiry and collaboration, ensuring his legacy will resonate for years to come.

📖Notable Publications

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema
  • Authors : Li, H., Liu, S., Dai, W., … Jin, F., Jiang, L.
  • Journal: Controlled Release
  • Year: 2024
Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells
  • Authors : Wang, Y., Wei, H., Song, Z., … Shu, Q., Xie, Y.
  • Journal: Ginseng Research
  • Year: 2024
Dry Powder Formulations for Inhalation Require a Smaller Aerodynamic Diameter for Usage at High Altitude
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy